2766 Safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Data from the ANTHALYA trial
F. Selle, S. Gouy, E. Lambaudie, F. Guyon, V. Fourchotte, C. Pomel, P.E. Colombo, E. Kalbacher, S. Martin-Francoise, R. Fauvet, …
European journal of cancer (1990), Vol.51, pp.S553-S553
2766 Safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Data from the ANTHALYA trial
Créateurs - sans rôle
F. Selle
S. Gouy
E. Lambaudie
F. Guyon
V. Fourchotte
C. Pomel
P.E. Colombo
E. Kalbacher
S. Martin-Francoise
R. Fauvet
P. Follana
A. Lesoin
F. Lecuru
V. Menguy
Y. Ghazi
E. Chereau
S. Zohar
P. Cottu
F. Joly
R. Rouzier
Détails de publication
European journal of cancer (1990), Vol.51, pp.S553-S553
Identifiants
99140128909311
Unité académique
Institut de Recherche en Cancérologie de Montpellier - IRCM